Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memory, Ageing, and the Cholinergic System
2008-008896-32Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of rivastigmine in Mild Cognitive Impairment (MCI) (2 arms), sponsored by University of Cologne. Primary endpoint: Between-group difference in the correlation between regional MP4A activity and brain activity underlying memory and attention functions. Started Jul 2009; status: completed.
02
Drugs
rivastigmine
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on 2008-008896-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008896-32.